Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer

473 indexed citations
published 1992

Countries where authors are citing Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer

Specialization
Citations

This map shows the geographic impact of Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer more than expected).

Fields of papers citing Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer.

About Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer

This paper, published in 1992, received 473 indexed citations . Written by K. Nygaard, Steinar Hagen, Hanne Sand Hansen, Reidulv Hatlevoll, Ragnar Hultborn, Anders Jakobsen, M Mäntylä, Hans Modig, Eva Munck‐Wikland and Bengt Rosengren covering the research area of Oncology, Pulmonary and Respiratory Medicine and Surgery. It is primarily cited by scholars working on Surgery (467 citations), Pulmonary and Respiratory Medicine (463 citations) and Oncology (31 citations). Published in World Journal of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1007/bf02067069.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026